The formal in vitro cytotoxicity test is a definitive biological safety evaluation performed in accordance with ISO 10993-5, designed to quantify the toxic potential of medical devices and biomaterials using standardized mammalian cell culture systems. As the foundational test in every biocompatibility testing program, it provides regulatory-grade quantitative data on cell viability and morphological response. This article explains the test principle, sample requirements, methodology, evaluation criteria, and practical applications of the formal cytotoxicity evaluation.
Technical Overview
The formal in vitro cytotoxicity test is a fully documented, quantitative biological evaluation performed to determine whether a medical device, material, or extract releases substances that are toxic to cultured mammalian cells. The test is conducted in accordance with ISO 10993-5 (Biological Evaluation of Medical Devices – Part 5: Tests for In Vitro Cytotoxicity), and in China it is implemented in parallel with the harmonized national standard GB/T 16886.5. Unlike preliminary screening evaluations, the formal test follows a validated protocol with defined controls, specified cell lines, standardized extraction conditions, and quantitative acceptance criteria, making the resulting report directly suitable for regulatory submissions.
Cytotoxicity is typically the first biological test performed in a biocompatibility assessment program because it is rapid, sensitive, and cost-effective compared with animal-based tests. A non-cytotoxic result supports the decision to proceed with additional biological evaluations such as sensitization, irritation, and systemic toxicity testing. A cytotoxic result, by contrast, triggers material reformulation, process review, or extractable and leachable studies to identify the causative agent.
Testing Samples
Final Products and Device Components
The formal test should ideally be performed on the final product in its final, sterilized, and packaged condition, since sterilization residues, processing aids, and sterilization method (ethylene oxide, gamma irradiation, steam) can all influence cytotoxic outcomes. Representative samples include catheters, syringes, infusion sets, wound dressings, implants, dental materials, condoms, gloves, and tubing sets.
Polymeric, Metallic, and Ceramic Materials
- Polymer materials: plastics, silicones, polyurethanes, PVC, latex, hydrogels, adhesives, and packaging films
- Metallic materials: titanium alloys, stainless steel, cobalt-chromium alloys, and nitinol used in orthopedic and cardiovascular implants
- Ceramic and composite materials: dental ceramics, bioactive glasses, bone substitutes, and coating materials
- Liquids and gels: lubricants, cleaning agents, and topical formulations in contact with tissue
Sample Preparation and Extraction
Sample preparation follows ISO 10993-12. Test samples are extracted under sterile conditions at a standardized ratio of sample surface area or mass to extraction vehicle volume, commonly 6 cm²/mL for surface-area-based sampling or 0.1–0.2 g/mL for mass-based sampling. Extraction vehicles typically include complete culture medium (such as MEM supplemented with serum) and physiological saline to cover both polar and non-polar extractables. Standard extraction conditions are 37°C ± 1°C for 24 ± 2 hours, with alternative conditions (for example, 50°C for 72 hours, 70°C for 24 hours, or 121°C for 1 hour) permitted when justified to simulate exaggerated or clinical exposure.
Testing Items
The formal cytotoxicity evaluation generates both qualitative and quantitative data sets, which together support the final pass or fail conclusion:
- Quantitative cell viability: the percentage of viable cells after exposure relative to the negative control, determined using colorimetric or fluorometric endpoints
- Morphological observation: microscopic examination of cell detachment, rounding, lysis, vacuolization, and membrane integrity
- Reactivity grading: qualitative scoring of the zone of lysis, malformation, and detachment under and around the sample on a graded scale from 0 (no reactivity) to 4 (severe reactivity)
- Metabolic activity assessment: measurement of mitochondrial function, lysosomal uptake, or membrane permeability depending on the selected endpoint
According to ISO 10993-5, a test sample is considered to have a cytotoxic potential when cell viability is reduced to below 70% of the negative control, meaning a viability reduction greater than 30% constitutes a cytotoxic effect in the quantitative method.
Testing Methods
Extract Method (Indirect Contact)
The extract method is the most widely applied approach in formal testing. The sterile extract is applied to a confluent monolayer of L929 mouse fibroblast cells (or another validated line such as V79 or BALB/3T3) cultured in 96-well plates. After an exposure period of 24 to 48 hours at 37°C in a humidified incubator with 5% carbon dioxide, cell response is quantified. This method is preferred for devices that contact the patient only through released substances and accommodates virtually any sample geometry.
Direct Contact Method
In the direct contact method, a sterile sample piece is placed directly onto the cell monolayer. This approach is suitable for low-density materials and evaluates both extractable toxicity and physical interaction between the material and cells. Care is taken to prevent mechanical damage to the monolayer, and results are interpreted with qualitative grading supported by viability measurement.
Indirect Contact Methods (Agar Diffusion and Filter Diffusion)
The agar diffusion method places the sample on an agar overlay above the cell layer, allowing diffusible toxic substances to reach the cells while protecting them from mechanical stress. The filter diffusion method positions cells on a cellulose filter that contacts the sample surface. Both methods deliver qualitative zone-of-reactivity grades and are useful for evaluating flat materials and solid finished products.
Endpoint Detection Techniques
- MTT assay: reduction of yellow tetrazolium salt to purple formazan crystals by metabolically active cells, measured by absorbance at 570 nm
- Neutral red uptake (NRU) assay: measurement of lysosomal accumulation of neutral red dye in viable cells
- XTT, WST-1, and resazurin (Alamar Blue) assays: water-soluble tetrazolium and resazurin-based alternatives offering simplified workflows
- Colony forming efficiency: quantification of clonogenic survival following extended incubation, applicable to slowly acting toxicants
- Lactate dehydrogenase (LDH) release: detection of cytoplasmic enzyme leakage as an indicator of membrane damage
Controls and Validity Criteria
Each formal test includes a negative control (typically high-density polyethylene film or untreated cells) and a positive control (such as dilute Triton X-100 solution, zinc diethyldithiocarbamate, or natural rubber latex). The test is valid only when the negative control produces grade 0–1 reactivity and viability near 100%, while the positive control demonstrates a clear cytotoxic response. Cell culture sterility, passage number limits, and confluence requirements are documented to satisfy laboratory quality system and data integrity expectations.
Applications
Regulatory Registration and Market Approval
The formal cytotoxicity test report is a mandatory element of biocompatibility documentation for medical device registration worldwide, including national market submissions, premarket notifications in the United States, and CE technical files under the European Medical Device Regulation. Reviewers expect the report to reference ISO 10993-5, describe the test method and rationale, present viability data with controls, and state a clear conclusion.
Biocompatibility Test Program Design
Cytotoxicity data feed directly into the chemical and biological safety assessment required by ISO 10993-1. The result determines whether additional biological endpoints are needed and supports the biological evaluation plan and risk management file under ISO 14971.
Product Development and Material Screening
- Comparative screening of candidate polymers, additives, colorants, and adhesives before tooling investment
- Verification of process changes, new suppliers, sterilization validation, and reformulated materials
- Evaluation of packaging interaction, residual monomers, degradation products, and surface coatings
- Support for dental, orthopedic, wound care, ophthalmic, and drug-device combination products
Result Interpretation and Reporting
A compliant formal report includes the test standard, cell line and passage number, extraction conditions and ratios, methodology, viability percentages for test and control groups, statistical analysis, morphological observations, reactivity grades, and a conclusion stating whether the sample meets the ISO 10993-5 acceptance criterion. Reports issued by accredited third-party laboratories operating under ISO/IEC 17025 quality systems carry the strongest regulatory acceptance.
FAQ
What is the difference between a preliminary screening test and a formal cytotoxicity test?
A preliminary screening test is an internal, simplified evaluation used during early development to identify obvious toxicity, often without full control sets or documentation. A formal test follows the complete validated protocol with negative and positive controls, defined extraction ratios, replicates, statistical evaluation, and a GLP-style or ISO/IEC 17025-compliant report suitable for regulatory submission.
Which cell line is used most commonly?
The L929 mouse connective tissue fibroblast line is the most widely used cell type because ISO 10993-5 historically established its use and extensive historical data exist. V79 and BALB/3T3 cells are accepted alternatives, and primary human cells may be used with scientific justification.
What is the pass criterion for the formal test?
For the quantitative extract method, the sample passes when the mean cell viability is equal to or greater than 70% of the negative control. For qualitative methods, a reactivity grade of 0, 1, or 2 generally indicates the sample meets requirements, subject to the test plan rationale.
How long does a formal cytotoxicity test take?
Typical laboratory turnaround is 10 to 15 working days, covering cell culture preparation, 24-hour extraction, 24 to 48 hour exposure, endpoint measurement, and report compilation. Complex samples requiring method development or multiple extraction vehicles may require additional time.
How much sample is required for testing?
Generally, a sample quantity yielding at least 6 cm² of contacting surface per milliliter of extraction vehicle, or 0.1 to 0.2 g per milliliter for irregular materials, is required. Laboratories typically request finished, sterilized products in their final packaging, with two to three complete devices to ensure sufficient extract volume for duplicates and controls.
Does a cytotoxic result always mean the product fails?
Not necessarily. A cytotoxic result identifies a hazard that must be evaluated within the risk management framework. Root cause analysis, such as identifying residual sterilant, processing additive, or degradation product, combined with engineering controls or material substitution, can resolve the finding before retesting confirms compliance.
